Artificial Tears Solution/ Drops
FDA Recall NDC 68788-7266
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Artificial Tears (NDC 68788-7266). A significant event, classified as Class II, was initiated on Mar 25, 2026 by Preferred Pharmaceuticals Inc.. The reported reason for this action was: "Lack of Assurance of Sterility"
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
Reported Recall Events
Class II Ongoing
Lack of Assurance of Sterility
Mar 25, 2026
Apr 15, 2026
720 bottles
Recall Profile & Regulatory Data
Event ID
98687
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
Preferred Pharmaceuticals, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide within the United States
Product Description
Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0
Batch or Lot Expiration Information
Lot# : F1924R, F2024G, F2424E, G2424M, G2624P, J2424M
Affected Packages Involved in this Recall
68788-7266-0Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
